[Clinical analysis of ear symptoms of 40 patients with ANCA-associated vasculitis]

[40例ANCA相关性血管炎患者耳部症状的临床分析]

阅读:1

Abstract

Objective:To analyze the clinical feature, diagnosis and treatment of Anca-associated vasculitis with ear symptoms. Methods:In this retrospective study, we summarized the clinical and laboratory examination, pure tone audiometry, aural immittance measurement, CT scan of temporal bone and treatment of 40 patients in the First Medical Center of the PLA General Hospital. Results:A total of 11 cases(27.5%) had the initial symptom in the ear. The most common symptoms were hearing loss, and the other symptoms included a sense of ear fullness, otorrhea and tinnitus. There were 35 cases with hearing loss: 19 cases with conductive hearing loss(47.5%), 9 cases with sensorineural hearing loss(22.5%), and 7 cases with mixed hearing loss(17.5%). 5 cases had a sense of ear fullness or tinnitus, and the results of the hearing test were normal(12.5%). All of the 40 patients had multi-system involvement, and respiratory system accounted for the most. All patients had a positive result of Anti-neutrophil cytoplasmic antibody(ANCA). Treatment included systemic hormonal, immunosuppressive, or biologic therapy. There were 3 cases recovered(7.5%), 22 cases with alleviated ear symptoms(55.0%), 6 cases with recurrent hearing loss(15%) and 9 cases had no significant improvement(22.5%). Conclusion:Conductive deafness(secretory otitis media) can be the first manifestation in the early stage of otitis media with AAV(OMAAV), later it may turn to binaural mixed deafness. Otolaryngologists need to consider OMAAV diagnosis when diagnosing and treating patients with recurrent secretory otitis media. Multi-system symptom consultation and ANCA examination can help identify. Early systemic medication and the application of immunosuppressants or biological agents can help relieve the ear symptoms.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。